Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bain Capital
Biotech
Kailera launches with $400M series A, 4 Chinese obesity drugs
Kailera has launched into the increasingly crowded obesity space with a portfolio of assets acquired from China and $400 million in series A funds.
James Waldron
Oct 1, 2024 8:30am
Bain unveils $3B fund for life science companies
Sep 10, 2024 11:20am
Medtech M&A, VC funding slowed in H1 2023: Evaluate
Jul 10, 2023 10:19am
Cerevel to change up CEO as 7 data readouts near showdown
May 3, 2023 6:30am
JenaValve nabs $100M to clear TAVR system’s FDA pathway
Aug 31, 2022 3:35pm
Olympus inks $3B sale of scientific tools unit to Bain Capital
Aug 29, 2022 10:19am
